Genetic Therapy Shows Promise in Halting ALS
The CTx1000, a single-dose genetic medication, targets pathological accumulations of the TDP-43 protein, offering hope for treating various forms of dementia.
Source: medindia.net
Stay updated with breaking news from Enetic Medication. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The CTx1000, a single-dose genetic medication, targets pathological accumulations of the TDP-43 protein, offering hope for treating various forms of dementia.